Free Access
Issue
Réanimation
Volume 24, Number 1, Janvier 2015
Respiratoire
Page(s) 84 - 86
Section Letter to the Editor / Lettre À L’Éditeur
DOI https://doi.org/10.1007/s13546-014-1017-3
Published online 08 January 2015
  • Binder L, Pieske B, Olschewski M, et al (2005) N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 112:1573–1579 [CrossRef] [PubMed] [Google Scholar]
  • Kucher N, Printzen G, Goldhaber SZ (2003) Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 107:2545–2547 [CrossRef] [PubMed] [Google Scholar]
  • van der Meer RW, Pattynama PM, van Strijen MJ, et al (2005) Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism. Radiology 235:798–803 [CrossRef] [PubMed] [Google Scholar]
  • ten Wolde M, Söhne M, Quak E, Mac Gillavry MR, Büller HR (2004) Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Int Med 164:1685–1689 [CrossRef] [Google Scholar]
  • Goldhaber SZ, Kessler CM, Heit JA, et al (1992) Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol 20:24–30 [CrossRef] [PubMed] [Google Scholar]
  • Konstantinides S, Geibel A, Heusel G, et al (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347:1143–1150 [CrossRef] [PubMed] [Google Scholar]
  • Committee Steering (2012) Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: Rationale and design of the Pulmonary EmbolIsm THrOmbolysis (PEITHO) trial. The Steering Committee1. Am Heart J 163:33–38 [CrossRef] [PubMed] [Google Scholar]
  • Kline JA, Nordenholz KE, Courtney DM, et al (2014) Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost 12:459–468 [CrossRef] [PubMed] [Google Scholar]
  • Konstantinides SV, Torbicki A, Agnelli G, et al (2014) 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) endorsed by the European Respiratory Society (ERS). Eur Heart J 35:3033–3080 [CrossRef] [PubMed] [Google Scholar]
  • Mi YH, Liang Y, Lu YH, et al (2013) Recombinant tissue plasminogen activator plus heparin compared with heparin alone for patients with acute submassive pulmonary embolism. J Geriatr Cardiol 10:323–329 [PubMed] [Google Scholar]
  • Vieillard-Baron A, Page B, Augarde R, et al (2001) Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 27:1481–1486 [CrossRef] [PubMed] [Google Scholar]
  • Rose PS, Punjabi NM, Pearse DB (2002) Treatment of right heart thromboemboli. Chest 121:806–814 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.